Delivery Order SPE2DB22D2009-SPE2DB25FL8GU

Award Date 3/13/25
Potential Completion Date 3/14/25
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) has an award value of $1,658.24. The contract is for the delivery of fluticasone propionate HFA 110 mcg inhalers, with an ultimate completion date of March 3, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,126.40 firm-fixed-price delivery order is for the supply of Fluticasone Prop 50 MCG Spray 16GM, a prescription medication. The contract has a completion date of February 10, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,142.40 firm fixed-price delivery order is for the supply of fluticasone propionate 50 mcg spray, 16 gm. The contract has an ultimate completion date of February 5, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The award, worth $1,231.40, is for the supply of 4,563,395,615 units of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of January 23, 2024. This award is not designated with a set-aside requirement, indicating open...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,490.72 firm fixed-price delivery order is for the supply of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, to support military healthcare programs. The contract has a completion date of February 26, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,571.49 for the supply of Fluticasone Prop HFA 110 MCG 12GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of August 9, 2024. The contract is a Firm Fixed Price arrangement. Amerisourcebergen is supplying this pharmaceutical product as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Fluticasone 44mcg 1s, a pharmaceutical product, with a ceiling value of $1,632.36 and a period of performance through January 27, 2025. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at...
This federal contract award, valued at $2,786.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Fluticasone Propionate HFA 220 MCG 12GM, a pharmaceutical product, with a completion date of January 24, 2025. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,038.75 firm fixed-price delivery order is for the supply of 4566771118 - FLUTICASONE PROP 50 MCG SPRAY 16GM, a pharmaceutical product. The contract has an ultimate completion date of December 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,089.60 firm fixed-price delivery order is for the provision of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL8GU
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) under a $999,999,999 Indefinite Delivery Contract (IDC) to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific contract award is for the delivery of Fluticasone Prop 50 MCG Spray 16GM, with a ceiling value of $7,142.49 and a period of performance through March 2025. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive supply chain and distribution capabilities, as well as its significant presence in federal healthcare contracting, make it a key vendor for the DLA and other government agencies in delivering essential medical commodities, including specialty medications, generic drugs, vaccines, and medical devices, across various therapeutic areas.

Generated 6/12/25, 10:23 AM